EMPIRE ADVANCEMENTS LIMITED

Company number SC654950 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

EMPIRE ADVANCEMENTS LIMITED - Analysis Report

Company Number: SC654950

Analysis Date: 2025-07-29 20:57 UTC

Financial Health Assessment of EMPIRE ADVANCEMENTS LIMITED


1. Financial Health Score: C

  • Explanation:
    The company shows signs of moderate financial health with positive net assets and shareholders' funds but displays concerning trends in liquidity and reduced working capital. While not in immediate distress, there are symptoms that warrant attention to avoid potential financial strain.

2. Key Vital Signs

Metric 2024 Value Interpretation
Current Assets £2,076 Low and declining, indicating reduced short-term resources available to cover liabilities.
Cash at Bank £77 Critically low cash reserves, signaling potential liquidity stress ("weak pulse" in cash flow).
Debtors £2,000 Increase in receivables, which could strain cash flow if not collected promptly.
Current Liabilities £1,345 Relatively stable but significant compared to cash available.
Net Current Assets £731 Positive but substantially decreased from £2,314 in prior year, a key warning sign.
Net Assets (Equity) £731 Positive shareholders’ funds, indicating the company’s assets exceed liabilities.
Retained Earnings £730 Slight deficit during the year (-£27), reflecting operating losses impacting reserves.

Additional Context:

  • Company is Small category (Private Limited, incorporated 2020).
  • Industry: Buying and selling of own real estate (SIC 68100).
  • Single director with significant influence.
  • No audit requirement — accounts are unaudited, which may limit external verification.

3. Diagnosis: What the Numbers Reveal

  • Cash Flow Weakness:
    The company’s cash reserves have dropped dramatically from £2,613 in 2023 to just £77 in 2024. This "weak pulse" in liquid cash suggests the business might be struggling to generate or preserve cash, a critical symptom of financial distress in the short term.

  • Working Capital Decline:
    Net current assets have shrunk from £2,314 to £731, reflecting a waning buffer to cover immediate debts. This could lead to short-term liquidity issues if liabilities come due before cash is received.

  • Receivables Growing:
    Debtors increased from £557 to £2,000, which may indicate slower collections or extended credit terms. If these debts are not collected timely, the company’s liquidity could be further compromised.

  • Equity and Solvency Stable but Thin:
    Shareholders’ funds remain positive but have decreased slightly, indicating the company is solvent but with limited cushion against financial shocks.

  • Operating Performance:
    A modest loss of £27 in retained earnings suggests the company is operating near break-even, but ongoing losses could erode equity further.

  • No Long-term Debt:
    The bank loan reported last year (£1,556) has been fully repaid or reclassified, reducing financial burden and interest costs, which is positive.

  • Small Scale and Limited Resources:
    With minimal share capital (£1), the company depends heavily on operational cash flow and receivables management.


4. Recommendations: Actions to Improve Financial Wellness

  • Strengthen Cash Management:
    Focus urgently on improving cash flow by accelerating debtor collections and minimizing cash outflows. This is akin to stabilizing the patient’s heartbeat.

  • Review Credit Policies:
    Implement tighter credit control to reduce debtor days and avoid overextending credit to buyers, ensuring cash inflows are timely.

  • Enhance Working Capital Monitoring:
    Regularly track current assets and liabilities to anticipate liquidity needs and avoid short-term cash shortages.

  • Cost Control and Profitability Focus:
    Analyze expenses to identify cost-saving opportunities and aim to return to profitability, which will rebuild retained earnings and equity "immune system."

  • Consider Capital Injection:
    If cash flow issues persist, injecting equity or seeking short-term financing could provide the necessary liquidity buffer.

  • Maintain Compliance and Transparency:
    Continue timely filing of accounts and confirmation statements to avoid penalties and maintain stakeholder confidence.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.